Showing 14,561 - 14,580 results of 17,627 for search '"The Progressive"', query time: 0.10s Refine Results
  1. 14561

    Chronic periodontitis clinical and epidemiological characterization by Bernardo Pérez Barrero, Clara Ortiz Moncada, Walkyria del Carmen González Rodríguez, Lilian Judith Del Todo Pupo

    Published 2025-01-01
    “…<br /><strong>Conclusions</strong>: a high prevalence of chronic periodontitis was obtained, significantly associated with age and initiating risk factors, which were represented progressively according to the stages of the disease.…”
    Get full text
    Article
  2. 14562

    Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with castration-resistant prostate cancer treated with docetaxel-based chemotherapy: a meta-analysis by Ying Zhang, Xiao Zhou, Ran Xu, Guangcheng Luo, Xinjun Wang

    Published 2025-01-01
    “…RevMan 5.4.1 was used to summarize the hazard ratio (HR) and its 95% confidence interval (CI) for overall survival (OS) and progression-free survival (PFS) with subgroup analysis. …”
    Get full text
    Article
  3. 14563

    Influence of implant length on implant primary and secondary stability by Mauricio Toro, Javiera Leitao, Tomás Yoma, Alain Manuel Chaple Gil, Eduardo Fernández

    Published 2022-04-01
    “… Introduction: Implant stability can be measured at the moment of implant placement or once the osseointegration process is in progress. Many factors should be considered, including bone quality, osteotomy preparation, implant design, implant surface enhancement, and implant length and diameter. …”
    Get full text
    Article
  4. 14564

    Prognostic significance of mast cell and microvascular densities in malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1 by Roberto André Torres de Vasconcelos, Pedro Guimarães Coscarelli, Thyago Marsicano Vieira, Washington Silva Noguera, Davy Carlos Mendes Rapozo, Marcus André Acioly

    Published 2019-03-01
    “…The role of mast cells in tumor progression is unclear and lacks prognostic value. Higher MVD has prognostic significance with possible therapeutic implications in MPNST.…”
    Get full text
    Article
  5. 14565

    Optimal timing of organs-at-risk-sparing adaptive radiation therapy for head-and-neck cancer under re-planning resource constraints by Fatemeh Nosrat, Cem Dede, Lucas B. McCullum, Raul Garcia, Abdallah S.R. Mohamed, Jacob G. Scott, James E. Bates, Brigid A. McDonald, Kareem A. Wahid, Mohamed A. Naser, Renjie He, Aysenur Karagoz, Amy C. Moreno, Lisanne V. van Dijk, Kristy K. Brock, Jolien Heukelom, Seyedmohammadhossein Hosseinian, Mehdi Hemmati, Andrew J. Schaefer, Clifton D. Fuller

    Published 2025-01-01
    “…Background and purpose: Prior work on adaptive organ-at-risk (OAR)-sparing radiation therapy has typically reported outcomes based on fixed-number or fixed-interval re-planning, which represent one-size-fits-all approaches and do not account for the variable progression of individual patients’ toxicities. The purpose of this study was to determine the personalized optimal timing of re-planning in adaptive OAR-sparing radiation therapy, considering limited re-planning resources, for patients with head and neck cancer (HNC). …”
    Get full text
    Article
  6. 14566

    The Ukrainian war and the pandemic: the impact on public health and the need for new health digital tools and the next level of intelligence by M. Geanta, B. Cucos, A. Boata, A.C. Nuta, F.M. Nuta, V.V. Semenov

    Published 2023-12-01
    “…The aim: to review the progress regarding viral surveillance technologies that use genomics, digital, and informational tools, to find the gap in the literature and formulate policy recommendations for continuing surveillance in the context of permacrisis. …”
    Get full text
    Article
  7. 14567

    Search for clinical, genetic, morphological and immunohistochemical predictors of parathyroid cancer recurrence by Ekaterina I. Kim, Anna K. Eremkina, Alina R. Elfimova, Natalia G. Mokrysheva

    Published 2024-12-01
    “…The risk factors of disease progression are crucial for choosing the optimal treatment strategy, including adjuvant methods and patient,s follow-up. …”
    Get full text
    Article
  8. 14568

    Time Series Classification of Raw Voice Waveforms for Parkinson&#x0027;s Disease Detection Using Generative Adversarial Network-Driven Data Augmentation by Marta Rey-Paredes, Carlos J. Perez, Alfonso Mateos-Caballero

    Published 2025-01-01
    “…In this context, many recent studies have focused on the automatic detection and progression tracking of PD from voice-related characteristics, being feature engineering the most common approach. …”
    Get full text
    Article
  9. 14569

    Hyperlipidemia May Synergize with Hypomethylation in Establishing Trained Immunity and Promoting Inflammation in NASH and NAFLD by Charles I. V. Drummer, Fatma Saaoud, Yu Sun, Diana Atar, Keman Xu, Yifan Lu, Ying Shao, Candice Johnson, Lu Liu, Huimin Shen, Nirag C. Jhala, Xiaohua Jiang, Hong Wang, Xiaofeng Yang

    Published 2021-01-01
    “…Our findings provide novel insights on the synergies between hyperlipidemia and hypomethylation in establishing TI and promoting inflammation in NASH and NAFLD progression and novel targets for future therapeutic interventions for NASH and NAFLD, metabolic diseases, transplantation, and cancers.…”
    Get full text
    Article
  10. 14570

    Subject Advisors’ Understanding of their Curriculum Leadership Roles for Mathematics Improvement in South African Schools by Thabo France Sithole, Simon Adjei Tachie, Tafirenyika Mafugu

    Published 2024-10-01
    “…Many expressed a need for training, particularly in managing and supporting progressed learners. These findings suggest the need for a standardized model to guide leadership training for Mathematics subject advisors. …”
    Get full text
    Article
  11. 14571

    Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care by Daniela Tomasoni, Julie K.K. Vishram‐Nielsen, Matteo Pagnesi, Marianna Adamo, Carlo Mario Lombardi, Finn Gustafsson, Marco Metra

    Published 2022-06-01
    “…The number of patients that progress to an advanced stage of HF is growing. Only a limited proportion of these patients can undergo heart transplantation or mechanical circulatory support. …”
    Get full text
    Article
  12. 14572

    Congenital Malaria and Its Associated Factors at Issaka Gazobi Maternity of Niamey in Niger by I. Tahirou, M. O. Zara, M. L. Moustapha, M. Kamayé, D. Mahamadou, A. Ibrahim, M. Daou, A. Soumana, M. L. Ibrahim

    Published 2020-01-01
    “…In Niger, one out of four newborns is infected with Plasmodium. Infection can progress to congenital malaria disease. The use of mosquito nets and intermittent preventive treatment would reduce the incidence of congenital malaria.…”
    Get full text
    Article
  13. 14573

    Prevalence of Myopia among Children Attending Pediatrics Ophthalmology Clinic at Ohud Hospital, Medina, Saudi Arabia by Aisha Mohammed Alemam, Mohammed Hamad Aldebasi, Abdulkarem Rehmatullah, Rami Alsaidi, Ishraq Tashkandi

    Published 2018-01-01
    “…We hope that the results of this study will contribute to a better understanding of this public health issue in Saudi Arabia in order to implant a strict screening program for early detection and interventions to reduce the risk of further progression of visual impairment.…”
    Get full text
    Article
  14. 14574
  15. 14575

    Do goats recognise humans cross-modally? by Marianne A. Mason, Stuart Semple, Harry H. Marshall, Alan G. McElligott

    Published 2025-01-01
    “…Accordingly, heart rate decreased as the playback sequence progressed, but only when the face and voice presented were incongruent. …”
    Get full text
    Article
  16. 14576

    Risk factors and metabolic control degree in diabetic patients older than 8 years by Antonio Masot Rangel, Dinorah Janet Torres Lugo, Iván Castillo Ledo, Silvia Janet Masot Torres, Laura Vazquez Pis, Iriam Rojas Díaz

    Published 2024-11-01
    “…<p><strong>Foundation</strong>: Type 1 diabetes mellitus is one of the most common chronic diseases in childhood. The progressively longer survival of diabetic children is associated with an increase in the prevalence of complications. …”
    Get full text
    Article
  17. 14577

    The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer by M. P. Smal, A. I. Rolevich, T. N. Nabebina, S. A. Krasny, R. I. Goncharova

    Published 2015-12-01
    “…The aim of this study was to determine the frequency and spectrum of HRAS, KRAS and NRAS mutations, to analyze their relationships with clinicopathological variables and to determine the prognostic value of these alterations in terms of recurrence, progression and mortality, in a prospective cohort of 249 bladder cancer patients. …”
    Get full text
    Article
  18. 14578

    Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease by Hui Xu, Anakha Ajayan, Ralf Langen, Jeannie Chen

    Published 2025-02-01
    “…Thus, the eye may serve as a useful system to track disease progression and to test therapeutic intervention strategies for HD.…”
    Get full text
    Article
  19. 14579

    Clinical utility of tumour mutational burden on efficacy of immune checkpoint inhibitors in malignant solid tumours: protocol for a systematic review and meta-analysis by Xiaoguang Yang, Yunming Li, Xuemei Xiang, Wang Guo, Pengfei Zhou

    Published 2022-08-01
    “…We will compare the efficacy of ICIs between TMB high group and TMB low group in terms of the HRs of overall survival (OS) and progression-free survival (PFS), and the OR of the objective response rate/overall response rate (ORR). …”
    Get full text
    Article
  20. 14580

    Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma... by A. Visram, A. De La Torre, D. White, J. Su, E. Masih-Khan, M. Chu, V. Jimenez-Zepeda, A. McCurdy, R. LeBlanc, K. Song, H. Mian, M. Louzada, M. Sebag, D. Bergstrom, J. Stakiw, A. Reiman, R. Kotb, M. Aslam, C. Venner, R. Kaedbey, E. Gul, D. Reece

    Published 2023-12-01
    “…Overall, 663 patients had disease progression on anti-CD38 mAb therapy, 466 received further treatment (346 with SoC regimens were included, 120 with investigational agents on clinical trial and were excluded). …”
    Get full text
    Article